Abstract:Single naive B cells amplify and diversify their responses when activated by cognate antigen, via -dependent clonal expansion, immunoglobulin class switch recombination (CSR), phenotypic variation, and somatic hypermutation (SHM). Whether these mechanisms act combinatorially to diversify clonal responses to a single complex pathogen remains unclear. Since diversity in the antigenic targets, functional classes, and production kinetics of parasite-specific antibodies influences immunity to malaria, we test here whether individual B cell clones diversify over time during infection and treatment. During the first week of infection, amid widespread Type I Interferon (IFN)-mediated, bystander activation, CSR initiates soon after up-regulation. CSR then overlaps with clonal expansion, resulting in isotype variegation amongst certain clones. In the second week of infection, expanded clones seeding germinal centres (GC) both bifurcate into extra-follicular plasmablasts and exhibit isotype variegation, revealing substantial intra-clonal diversification. Over the following month, GC clones undergo SHM at approximately four mutations per week, with IgG mutational diversity and IgM cells preserved in GCs over time. Anti-malarial intervention does not impede SHM, but instead exerts quantitative limits on GC size, plasma cell emergence and circulating antibody titres. Finally, we reveal a contemporaneous B cell developmental pathway that relocates from bone marrow to the spleen during infection and treatment. Thus, multiple temporally overlapping mechanisms combine to amplify, diversify, and safeguard humoral immune responses.

Temporally overlapping mechanisms diversify clonal B cell responses .